Emotional Freedom Techniques in Nursing Students With Primary Dysmenorrhea (NCT07658859) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Emotional Freedom Techniques in Nursing Students With Primary Dysmenorrhea
92 participantsStarted 2026-06-19
Plain-language summary
This study will examine whether Emotional Freedom Techniques (EFT) can reduce pain intensity, pain catastrophizing, and functional-emotional impact in nursing students with primary dysmenorrhea. Eligible participants will be randomly assigned to an intervention group or a control group. The intervention group will receive EFT-based support, and the control group will continue their usual coping practices. Study outcomes will be measured before the intervention, after the intervention, and at follow-up. This study may provide evidence for a safe, non-pharmacological approach to support students with primary dysmenorrhea.
Who can participate
Age range
18 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Being enrolled in a nursing program,
* Being 18 years of age or older
* Having had a regular menstrual cycle within the last six months
* Experiencing primary dysmenorrhea during the last three menstrual cycles
* Reporting moderate to severe pain according to the Visual Analog Scale (VAS: 4-10)
* Voluntary participation in the study
* Providing written informed consent
Exclusion Criteria:
* Having a diagnosed gynecological disease that may cause secondary dysmenorrhea (endometriosis, adenomyosis, uterine fibroids, pelvic inflammatory disease, etc.)
* Having chronic pain syndrome
* Receiving regular treatment or taking psychiatric medication due to a psychiatric diagnosis
* Applying another pharmacological or non-pharmacological intervention that may affect pain perception during the research process,
* Taking the course Obstetrics, Gynecology and Women's Health Nursing • Receiving/having received emotional freedom technique training,
* Having previously received training in this technique or regularly using it
* Having a cognitive or sensory problem that prevents communication or completing data collection forms
* Not completing the application protocol
* Incomplete completion of data collection forms
* Wishing to withdraw from the research
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Pain Intensity
Timeframe: Baseline (T0), post-intervention (T1; 2-3 days after the end of menstrual bleeding in the intervention cycle), and follow-up (T2; 2-3 days after the end of menstrual bleeding in the next menstrual cycle)
2
Pain Catastrophizing
Timeframe: Baseline (T0), post-intervention (T1; 2-3 days after the end of menstrual bleeding in the intervention cycle), and follow-up (T2; 2-3 days after the end of menstrual bleeding in the next menstrual cycle)
3
Functional-Emotional Impact
Timeframe: Baseline (T0), post-intervention (T1; 2-3 days after the end of menstrual bleeding in the intervention cycle), and follow-up (T2; 2-3 days after the end of menstrual bleeding in the next menstrual cycle)